01.
Phase 01
Weight Loss Spray
Appetite support and metabolic activation for the active fat-loss phase. Take it where willpower runs thin.
Save 15% with monthly auto-refill
Two sprays. One weight journey.
Support the loss.
Defend the result.
Finally.
Oprimaze pairs a weight loss spray with a weight maintenance spray — hemp-derived, fast-absorbing nasal delivery built around the two phases that actually matter: getting there, and staying there.
Free shipping over $74.90 · 30-day guarantee
Nasal delivery
No needles, no pills
Hemp-derived
THCV · CBD · CBC blend
Contains no THC
Made to be non-detectable on standard workplace drug screens — check with your employer or testing provider first
Fast onset
Effects in minutes
The system
Two sprays. Two phases. One outcome.
02.
Phase 02
Weight Maintenance Spray
Metabolic stability and appetite regulation for the maintenance phase — support for the window when regain risk runs highest.
Save 15% with monthly auto-refill
80%.
regain within 5 years without structured maintenance
— Wing & Phelan, 2005
⅔.
regain within 12 months of stopping injectable therapy
— Wilding et al., Diabetes Obes Metab 2022
34–46%.
intranasal bioavailability vs. 6–19% oral
— Paudel et al., Drug Dev Ind Pharm 2010 (cannabidiol)
0.
needles, sugars, or stimulant crashes
— Oprimaze formulation
“Losing the weight is the start. Keeping it off is the win.”
Two sprays. Two phases. One outcome.
The position
What's missing — and what we deliver.
What's missing
- One product for two distinct phases
- Slow, low-bioavailability oral delivery
- Needles, GI side effects, or stimulants
- No support after the weight comes off
What Oprimaze delivers
- Two sprays for two distinct phases
- Fast nasal delivery, minutes not hours
- Hemp-derived actives (THCV · CBD · CBC), clean labels
- A maintenance ritual designed to keep results
Free guide
Stepping off a GLP-1? The regain window starts now.
The GLP-1 exit plan covers the 12-month window after treatment ends — what the published research says happens, and the four-step plan for keeping your result.
The evidence
The science behind both solutions.
34–46%.
Intranasal bioavailability vs. 6–19% oral
— Cannabidiol delivery research — not an Oprimaze measurement
<10 min.
Average onset for nasal cannabinoids
— Delivery-science research
0g.
Added sugar in either formula
— Oprimaze label
0.
THC — the active is THCV; made to be non-detectable on standard workplace drug screens
— Third-party tested
These figures describe published delivery science and our own product data — not Oprimaze clinical-trial results.
Two solutions. One complete system.
Phase 01 supports active loss. Phase 02 supports maintenance. Same nasal spray format — no needles, no nausea.
Free shipping over $74.90 · 30-day guarantee